Skip to content

Is 3D Modeling From Non-contrast CT Accurate for Minimally Invasive Lung Segmentectomies ?

Is 3D Modeling From Non-contrast CT Accurate for Minimally Invasive Lung Segmentectomies ?

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07234604
Acronym
3D-LS
Enrollment
50
Registered
2025-11-18
Start date
2025-12-01
Completion date
2026-12-01
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Non-Small Cell Lung Cancer

Keywords

Lung cancer, Segmentectomy, 3D reconstruction, Computed tomography, Minimally invasive surgery

Brief summary

To assess the RELIABILITY in terms of accuracy of 3D-CT and 2D-CT reconstructions compared to intraoperative data regarding bronchovascular anatomy and tumor location. 3D CT reconstruction (CT scan without contrast injection) with Innersight3D® is equivalent to 2D CT (CT scan with contrast injection) for planning a minimally invasive lung segmentectomy. Evaluate the impact of 3D reconstruction (from a CT scan without injection of contrast agent) on intraoperative and postoperative results

Interventions

DIAGNOSTIC_TESTThoraco-abdomino-pelvic CT scan without and with contrast injection.

Eligible patients undergo the usual preoperative procedure, including consultations and CT scan with and without contrast injection.

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient ≥ 18 years * Patient agreeing to participate in the study * Patient with clinical stage IA lung lesions ≤ 2 cm in diameter AND a suspected or proven malignancy. * Chest CT scan available without and then with contrast * Eligible for VATS or RATS segmentectomy based on respiratory explorations

Exclusion criteria

* Patient refusal to participate in the study * Allergic reactions to radiographic contrast agents * History of ipsilateral cardiothoracic surgery * Open segmentectomy (thoracotomy) * Histology different from that of NSCLC * Inability to provide the subject with informed information (difficulty understanding the subject, insufficient command of French, etc.) * Pregnant or breastfeeding women * Severe cognitive impairment and/or suspicion of lack of compliance or adherence, in the investigator's judgment

Design outcomes

Primary

MeasureTime frameDescription
RELIABILITY of 3D-CT and 2D-CT reconstructions regarding bronchovascular anatomy and tumor location - composite 1Immediately after surgeryAccuracy between predicted bronchovascular anatomy by 3D CT and 2D CT reconstruction compared to intraoperative observations
RELIABILITY of 3D-CT and 2D-CT reconstructions regarding bronchovascular anatomy and tumor location - composite 2Immediately after surgeryAccuracy between predicted tumor location by 3D CT and 2D CT reconstruction compared to intraoperative observations

Countries

France

Contacts

Primary ContactPierre-Emmanuel FALCOZ, MD, PhD
pierre-emmanuel.falcoz@chru-strasbourg.fr33 3 69 55 08 54
Backup ContactChloé Moinet, Resident doctor
chloe.moinet@chru-strasbourg.fr33 3 69 55 08 54

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026